tiprankstipranks
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market
Want to see DRMA full AI Analyst Report?

Dermata Therapeutics (DRMA) Technical Analysis

154 Followers

Technical Sentiment

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
9Bullish
0Neutral
3Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Dermata Therapeutics is a Sell.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 1.26, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Buy.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 1.28, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Buy.

Dermata Therapeutics (DRMA) Pivot Points

Jul 06, 2026, 07:09 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.15
1.21
1.30
1.35
1.44
1.50
1.58
Fibonacci
1.21
1.27
1.30
1.35
1.41
1.44
1.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Jul 06, 2026, 07:09 AM
Period
Simple
Exponential
MA5
1.32Buy
1.32Buy
MA10
1.26Buy
1.29Buy
MA20
1.24Buy
1.26Buy
MA50
1.26Buy
1.28Buy
MA100
1.28Buy
1.55Sell
MA200
2.25Sell
2.61Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 1.29, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Buy.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 1.55, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 1.26, creating a Buy signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 1.28, creating a Buy signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 2.25, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Jul 06, 2026, 07:09 AM
Name
Value
Implied Action
RSI (14)
56.43
Neutral
STOCH (9,6)
67.21
Neutral
STOCHRSI (14)
67.21
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
24.56
Neutral
Williams %R
-45.16
Buy
CCI (14)
180.73
Sell
ATR (14)
0.11
-
Ultimate Oscillator
45.63
Neutral
ROC
9.84
Buy
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 56.43, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 24.56, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is 180.73, creating a Sell signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is 9.84, creating a Buy signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Buy.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 56.43, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is 0.02, which suggests DRMA is a Sell.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 1.32, which suggests DRMA is a Buy.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 1.24, which suggests DRMA is a Buy.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 1.26, which suggests DRMA is a Buy.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 2.25, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -45.16, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is 180.73, which suggests DRMA is a Sell.